Corlopam

Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
NDA019922 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fenoldopam Injection Is A Dopaminergic Agonist Indicated: • In Adult Patients For Short Term Management Of Severe Hypertension When Rapid And Reversible Reduction Of Blood Pressure Is Clinically Indicated, Including For Malignant Hypertension With Deteriorating End-Organ Function ( 1.1 ). • In Pediatric Patients For Short-Term Reduction In Blood Pressure ( 1.2 ). 1.1 Adult Patients Fenoldopam Is Indicated For In-Hospital, Short-Term (Up To 48 Hours) Management Of Severe Hypertension When Rapid, But Quickly Reversible, Emergency Reduction Of Blood Pressure Is Clinically Indicated, Including Malignant Hypertension With Deteriorating End-Organ Function. Transition To Oral Therapy With Another Agent Can Begin At Any Time After Blood Pressure Is Stable During Fenoldopam Infusion. 1.2 Pediatric Patients Fenoldopam Is Indicated For In-Hospital, Short-Term (Up To 4 Hours) Reduction In Blood Pressure [ See Clinical Pharmacology ( 12.2 ) ].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fenoldopam Mesylate FENOLDOPAM MESYLATE ZINC22116612

Comments